1. Pharmacological effects are model specific in animal models of portal hypertension

   • Flemming Bendtsen
   • Søren Møller

   Editorial 03 September 2008 Pages: 397 - 398

2. Biliary complications in liver transplantation

   • See Ching Chan
   • Sheung Tat Fan

   Review Article Open access 03 September 2008 Pages: 399 - 404

   

3. Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy

   • Angela Douglass
   • Karen Wallace
   • Matthew C. Wright

   Review Article Open access 03 September 2008 Pages: 405 - 415

   

4. Pathogenetic background for treatment of ascites and hepatorenal syndrome

   • Søren Møller
   • Jens H. Henriksen
   • Flemming Bendtsen

   Review Article 20 September 2008 Pages: 416 - 428

   

5. Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver

   • Shiv Kumar Sarin
   • Ashish Kumar
   • APASL Working Party on Portal Hypertension

   Review Article 05 September 2008 Pages: 429 - 439

6. A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B

   • Hie-Won Hann
   • Vicki L. Gregory
   • Keith F. Barker

   Review Article 21 October 2008 Pages: 440 - 456

7. Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension

   • Lionel Fizanne
   • Nicolas Régenet
   • Paul Calès

   Original Article 12 April 2008 Pages: 457 - 464

8. A 7-day profile of oxidative stress and antioxidant status in patients with acute liver failure

   • Vikram Bhatia
   • Payal Bhardwaj
   • Anoop Saraya

   Original Article 16 September 2008 Pages: 465 - 470

   

9. Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan^®) before curative resection of hepatocellular carcinoma: a pilot study

   • Seung Up Kim
   • Sang Hoon Ahn
   • Kwang-Hyub Han

   Original Article Open access 09 September 2008 Pages: 471 - 477

   

10. Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii

    • Naoky C. S. Tsai
    • Peter S. Holck
    • Aldrich A. Ricalde

    Original Article 15 October 2008 Pages: 478 - 485

    

11. Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study

    • Guangbi Yao
    • ChengWei Chen
    • Cyril Llamoso

    Original Article Open access 30 August 2008 Pages: 486 - 493

    

12. Pretreatment and on-treatment predictors of viral breakthrough in lamivudine therapy for chronic hepatitis B

    • Shahinul Alam
    • Golam Azam
    • Mobin Khan

    Original Article 05 September 2008 Pages: 494 - 497

13. Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

    • Shilen Lakhani
    • Lev Davidson
    • Averell H. Sherker

    Case Report 02 October 2008 Pages: 498 - 499

    

14. A case of primary small cell carcinoma of the liver that was treated with chemotherapy

    • Hiroyasu Morikawa
    • Yuji Nakayama
    • Norifumi Kawada

    Case Report Open access 22 August 2008 Pages: 500 - 504

    

15. Summary of the 2nd Asia Pacific Association for the Study of the Liver Diseases (APASL) Autumn Single Topic Conference 2007 The Innovation in Chronic Hepatitis B Treatment

    • Chutima Pramoolsinsap

    Others (Announcements, etc.) 15 April 2008 Pages: 505 - 505